Efficacy of Coronary Sinus Reducer in Patients With Non-revascularized Chronic Total Occlusions
- 1 July 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 126, 1-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- First-in-Human Use of Coronary Sinus Reducer in Patients With Refractory AnginaJACC, 2018
- Safety and efficacy of the reducer: A multi-center clinical registry - REDUCE studyInternational Journal of Cardiology, 2018
- Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experienceEuroIntervention, 2018
- A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusionsEuropean Heart Journal, 2018
- First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2017
- The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectivesEuropean Heart Journal, 2017
- Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experienceNetherlands Heart Journal, 2016
- Efficacy of a Device to Narrow the Coronary Sinus in Refractory AnginaNew England Journal of Medicine, 2015
- Effect of pressure-controlled intermittent coronary sinus occlusion on pacing-induced myocardial ischemia in domestic swine.Circulation, 1988
- The efficacy of intermittent coronary sinus occlusion in the absence of coronary artery collaterals.Circulation, 1987